{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:34:53Z","timestamp":1779291293553,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T00:00:00Z","timestamp":1473206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00428-016-2016-8","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T08:03:22Z","timestamp":1473235402000},"page":"697-706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14"],"prefix":"10.1007","volume":"469","author":[{"given":"Mathieu","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e8re","family":"Cacheux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Bret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariane","family":"Tempier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Guittard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Mac\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Leventoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Costes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Szablewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"2016_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ajh.23615","volume":"88","author":"JM Vose","year":"2013","unstructured":"Vose JM (2013) Mantle cell lymphoma: 2013 update on diagnosis, risk-stratification, and clinical management. Am J Hematol 88:1082\u20131088. doi: 10.1002\/ajh.23615","journal-title":"Am J Hematol"},{"key":"2016_CR2","unstructured":"Swerdlow SH, Campo E, Harris NL, et al. (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, France"},{"key":"2016_CR3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","volume":"96","author":"SL Ondrejka","year":"2011","unstructured":"Ondrejka SL, Lai R, Smith SD, et al. (2011) Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica 96:1121\u20131127. doi: 10.3324\/haematol.2010.036277","journal-title":"Haematologica"},{"key":"2016_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3109\/10428194.2013.815353","volume":"55","author":"ED Hsi","year":"2014","unstructured":"Hsi ED, Martin P (2014) Indolent mantle cell lymphoma. Leuk Lymphoma 55:761\u2013767. doi: 10.3109\/10428194.2013.815353","journal-title":"Leuk Lymphoma"},{"key":"2016_CR5","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1038\/leu.2012.72","volume":"26","author":"C Royo","year":"2012","unstructured":"Royo C, Navarro A, Clot G, et al. (2012) Non-nodal type of mantle cell lymphoma is a specific biological and clinical subgroup of the disease. Leukemia 26:1895\u20131898. doi: 10.1038\/leu.2012.72","journal-title":"Leukemia"},{"key":"2016_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1365-2141.2011.08962.x","volume":"156","author":"I Del Giudice","year":"2012","unstructured":"Del Giudice I, Messina M, Chiaretti S, et al. (2012) Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes. Br J Haematol 156:601\u2013611. doi: 10.1111\/j.1365-2141.2011.08962.x","journal-title":"Br J Haematol"},{"key":"2016_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3324\/haematol.2011.047357","volume":"96","author":"M Furtado","year":"2011","unstructured":"Furtado M, Rule S (2011) Indolent mantle cell lymphoma. Haematologica 96:1086\u20131088. doi: 10.3324\/haematol.2011.047357","journal-title":"Haematologica"},{"key":"2016_CR8","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/JCI61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E (2012) Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 122:3416\u20133423. doi: 10.1172\/JCI61272","journal-title":"J Clin Invest"},{"key":"2016_CR9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3324\/haematol.2011.055715","volume":"97","author":"J Slotta-Huspenina","year":"2012","unstructured":"Slotta-Huspenina J, Koch I, de Leval L, et al. (2012) The impact of cyclin D1 mRNA isoforms, morphology and p53 in mantle cell lymphoma: p53 alterations and blastoid morphology are strong predictors of a high proliferation index. Haematologica 97:1422\u20131430. doi: 10.3324\/haematol.2011.055715","journal-title":"Haematologica"},{"key":"2016_CR10","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1365-2141.2008.07199.x","volume":"142","author":"T Katzenberger","year":"2008","unstructured":"Katzenberger T, Kienle D, Stilgenbauer S, et al. (2008) Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis. Br J Haematol 142:538\u2013550. doi: 10.1111\/j.1365-2141.2008.07199.x","journal-title":"Br J Haematol"},{"key":"2016_CR11","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","volume":"94","author":"A Mozos","year":"2009","unstructured":"Mozos A, Royo C, Hartmann E, et al. (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94:1555\u20131562. doi: 10.3324\/haematol.2009.010264","journal-title":"Haematologica"},{"key":"2016_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/bjh.12854","volume":"166","author":"L Nordstr\u00f6m","year":"2014","unstructured":"Nordstr\u00f6m L, Sernbo S, Eden P, et al. (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma\u2014a Nordic Lymphoma Group study. Br J Haematol 166:98\u2013108. doi: 10.1111\/bjh.12854","journal-title":"Br J Haematol"},{"key":"2016_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3109\/10428199609067588","volume":"21","author":"S Pittaluga","year":"1996","unstructured":"Pittaluga S, Verhoef G, Criel A, et al. (1996) Prognostic significance of bone marrow trephine and peripheral blood smears in 55 patients with mantle cell lymphoma. Leuk Lymphoma 21:115\u2013125. doi: 10.3109\/10428199609067588","journal-title":"Leuk Lymphoma"},{"key":"2016_CR14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<850::AID-CNCR22>3.0.CO;2-Z","volume":"86","author":"KF Wong","year":"1999","unstructured":"Wong KF, Chan JK, So JC, et al. (1999) Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders. Cancer 86:850\u2013857","journal-title":"Cancer"},{"key":"2016_CR15","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","volume":"101","author":"J Orchard","year":"2003","unstructured":"Orchard J, Garand R, Davis Z, et al. (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101:4975\u20134981. doi: 10.1182\/blood-2002-06-1864","journal-title":"Blood"},{"key":"2016_CR16","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.3109\/10428194.2010.514968","volume":"51","author":"W Xu","year":"2010","unstructured":"Xu W, Li J-Y (2010) SOX11 expression in mantle cell lymphoma. Leuk Lymphoma 51:1962\u20131967. doi: 10.3109\/10428194.2010.514968","journal-title":"Leuk Lymphoma"},{"key":"2016_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fern\u00e0ndez","year":"2010","unstructured":"Fern\u00e0ndez V, Salamero O, Espinet B, et al. (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70:1408\u20131418. doi: 10.1158\/0008-5472.CAN-09-3419","journal-title":"Cancer Res"},{"key":"2016_CR18","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1158\/0008-5472.CAN-12-1615","volume":"72","author":"A Navarro","year":"2012","unstructured":"Navarro A, Clot G, Royo C, et al. (2012) Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical features. Cancer Res 72:5307\u20135316. doi: 10.1158\/0008-5472.CAN-12-1615","journal-title":"Cancer Res"},{"key":"2016_CR19","doi-asserted-by":"crossref","first-page":"18470","DOI":"10.1074\/jbc.274.26.18470","volume":"274","author":"M Muramatsu","year":"1999","unstructured":"Muramatsu M, Sankaranand VS, Anant S, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274:18470\u201318476","journal-title":"J Biol Chem"},{"key":"2016_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1146\/annurev.immunol.20.090501.112049","volume":"20","author":"T Honjo","year":"2002","unstructured":"Honjo T, Kinoshita K, Muramatsu M (2002) Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu Rev Immunol 20:165\u2013196. doi: 10.1146\/annurev.immunol.20.090501.112049","journal-title":"Annu Rev Immunol"},{"key":"2016_CR21","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.immuni.2004.05.011","volume":"20","author":"T Honjo","year":"2004","unstructured":"Honjo T, Muramatsu M, Fagarasan S (2004) AID: how does it aid antibody diversity? Immunity 20:659\u2013668. doi: 10.1016\/j.immuni.2004.05.011","journal-title":"Immunity"},{"key":"2016_CR22","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2015.02.006","volume":"185","author":"A Xochelli","year":"2015","unstructured":"Xochelli A, Sutton L-A, Agathangelidis A, et al. (2015) Molecular evidence for antigen drive in the natural history of mantle cell lymphoma. Am J Pathol 185:1740\u20131748. doi: 10.1016\/j.ajpath.2015.02.006","journal-title":"Am J Pathol"},{"key":"2016_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.humpath.2016.01.008","volume":"52","author":"Y Shi","year":"2016","unstructured":"Shi Y, Zhao X, Durkin L, et al. (2016) Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia. Hum Pathol 52:173\u2013178. doi: 10.1016\/j.humpath.2016.01.008","journal-title":"Hum Pathol"},{"key":"2016_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2160","author":"E Mahe","year":"2014","unstructured":"Mahe E, Akhter A, Le A, et al. (2014) PARP1 expression in mantle cell lymphoma: the utility of PARP1 immunohistochemistry and its relationship with markers of DNA damage. Hematol Oncol Published Online First. doi: 10.1002\/hon.2160","journal-title":"Hematol Oncol Published Online First"},{"key":"2016_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, et al. (2005) Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol 131:29\u201338. doi: 10.1111\/j.1365-2141.2005.05716.x","journal-title":"Br J Haematol"},{"key":"2016_CR26","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2005-10-4079","volume":"107","author":"T Katzenberger","year":"2006","unstructured":"Katzenberger T, Petzoldt C, H\u00f6ller S, et al. (2006) The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood 107:3407. doi: 10.1182\/blood-2005-10-4079","journal-title":"Blood"},{"key":"2016_CR27","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.exphem.2009.04.012","volume":"37","author":"N Kawamata","year":"2009","unstructured":"Kawamata N, Ogawa S, Gueller S, et al. (2009) Identified hidden genomic changes in mantle cell lymphoma using high-resolution single nucleotide polymorphism genomic array. Exp Hematol 37:937\u2013946. doi: 10.1016\/j.exphem.2009.04.012","journal-title":"Exp Hematol"},{"key":"2016_CR28","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1080\/10428190290016890","volume":"43","author":"A WY","year":"2002","unstructured":"WY A, Gascoyne RD, Viswanatha DS, et al. (2002) Cytogenetic analysis in mantle cell lymphoma: a review of 214 cases. Leuk Lymphoma 43:783\u2013791. doi: 10.1080\/10428190290016890","journal-title":"Leuk Lymphoma"},{"key":"2016_CR29","first-page":"699","volume":"36","author":"L Stefancikova","year":"2010","unstructured":"Stefancikova L, Moulis M, Fabian P, et al. (2010) Loss of the p53 tumor suppressor activity is associated with negative prognosis of mantle cell lymphoma. Int J Oncol 36:699\u2013706","journal-title":"Int J Oncol"},{"key":"2016_CR30","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1073\/pnas.0510441103","volume":"103","author":"TC Greiner","year":"2006","unstructured":"Greiner TC, Dasgupta C, Ho VV, et al. (2006) Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci U S A 103:2352\u20132357. doi: 10.1073\/pnas.0510441103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2016_CR31","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1073\/pnas.050400997","volume":"97","author":"C Schaffner","year":"2000","unstructured":"Schaffner C, Idler I, Stilgenbauer S, et al. (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A 97:2773\u20132778. doi: 10.1073\/pnas.050400997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2016_CR32","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Be\u00e0","year":"2013","unstructured":"Be\u00e0 S, Vald\u00e9s-Mas R, Navarro A, et al. (2013) Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc Natl Acad Sci U S A 110:18250\u201318255. doi: 10.1073\/pnas.1314608110","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2016_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/gcc.20754","volume":"49","author":"B Espinet","year":"2010","unstructured":"Espinet B, Salaverria I, Be\u00e0 S, et al. (2010) Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma. Genes Chromosomes Cancer 49:439\u2013451. doi: 10.1002\/gcc.20754","journal-title":"Genes Chromosomes Cancer"},{"key":"2016_CR34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.anndiagpath.2014.03.006","volume":"18","author":"J Chapman-Fredricks","year":"2014","unstructured":"Chapman-Fredricks J, Sandoval-Sus J, Vega F, et al. (2014) Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and\/or 13q14. Ann Diagn Pathol 18:214\u2013219. doi: 10.1016\/j.anndiagpath.2014.03.006","journal-title":"Ann Diagn Pathol"},{"key":"2016_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/emmm.201200229","volume":"4","author":"CT Williamson","year":"2012","unstructured":"Williamson CT, Kubota E, Hamill JD, et al. (2012) Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53. EMBO Mol Med 4:515\u2013527. doi: 10.1002\/emmm.201200229","journal-title":"EMBO Mol Med"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-2016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-016-2016-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-2016-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:07:30Z","timestamp":1498342050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-016-2016-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2016"],"URL":"https:\/\/doi.org\/10.1007\/s00428-016-2016-8","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]}}}